Genetic basis of anthracyclines cardiotoxicity: Literature review
The purpose of this review was to systematize data on molecular genetic markers of increased risk of cardiotoxic effects, as well as to search for risk and protective variants of candidate genes. Today, the therapy of malignant neoplasms is based on the use of anthracyclines – drugs of the cytostati...
Saved in:
Main Authors: | M. Yu. Sinitsky, A. V. Tsepokina, M. V. Khutornaya, A. V. Ponasenko, A. N. Sumin |
---|---|
Format: | article |
Language: | RU |
Published: |
Scientific Сentre for Family Health and Human Reproduction Problems
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/3824f05d5c5d4a4193d6bca3f450f543 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potential role of epicardial adipose tissue as a biomarker of anthracycline cardiotoxicity
by: Caterina Beatrice Monti, et al.
Published: (2021) -
Impacto cardiovascular secundario a la terapia para el control del cáncer
by: Ríos,Juvenal A., et al.
Published: (2020) -
Assesment of the TEI index of myocardial performance in dogs with doxorubicin-induced cardiomiopathy
by: Sousa,MG, et al.
Published: (2014) -
Weighted gene co-expression network-based approach to identify key genes associated with anthracycline-induced cardiotoxicity and construction of miRNA-transcription factor-gene regulatory network
by: Guoxing Wan, et al.
Published: (2021) -
<i>POLRMT</i> as a Novel Susceptibility Gene for Cardiotoxicity in Epirubicin Treatment of Breast Cancer Patients
by: Alejandro Velasco-Ruiz, et al.
Published: (2021)